- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02489643
Individualized Medical Training and Calcipotriol and Betamethasone Dipropionate Gel in Plaque Psoriasis
July 2, 2015 updated by: Giacomo Caldarola, Catholic University of the Sacred Heart
Role of an Individualized Medical Training in Improving Efficacy and Adherence to a 4-week Treatment With Calcipotriol and Betamethasone Dipropionate Gel for Mild-to-moderate Plaque Psoriasis
The aim of the study will be to evaluate the impact of this individualized practical training on efficacy (evaluated by Psoriasis Area and Severity Index (PASI) and Body Surface Area (BSA) score performed by a physician blinded to the study groups) and adherence (calculated as days wherein gel was applied and as BSA/weight of gel applied rate) to a 4 week long treatment with dovobet gel.
On the other hand, the investigators will evaluate in both groups as demographic (as sex, age, job,..) or disease (as severity, duration, impact of quality of life,..) characteristics influence the adherence to the treatment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of psoriasis will be maid mainly on clinical findings. If doubts, a skin sample will be obtained and evaluated by histopathological examination.
Exclusion Criteria:
- Patients with palmoplantar, scalp, inverse, erythrodermic, guttate, pustular psoriasis will be excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Receiving training
Patients will be visited and receive information about the prescribed topical treatment according to the normal course and procedure of an outpatient visit at our institution.
At the end of the visit, they will also receive practical instructions on dosages and application modalities of the topical therapy.
|
|
|
No Intervention: No-receiving training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Efficacy as measured by PASI improvement
Time Frame: 1 month
|
1 month
|
|
Efficacy as measured by BSA improvement
Time Frame: 1 month
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Adherence as measured by days wherein gel was applied
Time Frame: 1 month
|
1 month
|
|
Adherence as measured by BSA/weight of gel applied rate
Time Frame: 1 month
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2014
Primary Completion (Actual)
May 1, 2015
Study Registration Dates
First Submitted
June 29, 2015
First Submitted That Met QC Criteria
July 1, 2015
First Posted (Estimate)
July 3, 2015
Study Record Updates
Last Update Posted (Estimate)
July 7, 2015
Last Update Submitted That Met QC Criteria
July 2, 2015
Last Verified
July 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11134/14
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psoriasis
-
ProgenaBiomeWithdrawnPsoriasis | Psoriasis Vulgaris | Psoriasis of Scalp | Psoriatic Plaque | Psoriasis Universalis | Psoriasis Face | Psoriasis Nail | Psoriasis Diffusa | Psoriasis Punctata | Psoriasis Palmaris | Psoriasis Circinata | Psoriasis Annularis | Psoriasis Genital | Psoriasis GeographicaUnited States
-
Clin4allActive, not recruitingPsoriasis of Scalp | Psoriasis Nail | Psoriasis Palmaris | Psoriasis Genital | Psoriasis PlantarisFrance
-
Alumis IncActive, not recruitingPsoriasis | Plaque Psoriasis | Psoriasis (PsO) | Moderate Psoriasis | Severe PsoriasisUnited States, Canada, Australia, Germany, Spain, Hungary, Japan, Bulgaria, Poland, Czechia, Estonia, Latvia, Puerto Rico, Portugal, South Korea, France
-
Innovaderm Research Inc.CompletedScalp Psoriasis | Pustular Palmo-plantar Psoriasis | Non-pustular Palmo-plantar Psoriasis | Elbow Psoriasis | Lower Leg PsoriasisCanada
-
Caja Costarricense de Seguro SocialNot yet recruitingPsoriasis | Psoriasis (PsO) | Psoriasis Arthritis | Psoriasis PatientsCosta Rica
-
Centre of Evidence of the French Society of DermatologyRecruitingPsoriasis | Psoriasis Vulgaris | Psoriasis of Scalp | Psoriatic Plaque | Psoriasis Universalis | Psoriasis Palmaris | Psoriatic Erythroderma | Psoriatic Nail | Psoriasis Guttate | Psoriasis Inverse | Psoriasis PustularFrance
-
AmgenCompletedPsoriasis-Type Psoriasis | Plaque-Type PsoriasisUnited States
-
UCB Biopharma S.P.R.L.CompletedModerate to Severe Psoriasis | Generalized Pustular Psoriasis and Erythrodermic PsoriasisJapan
-
Janssen Pharmaceutical K.K.Active, not recruitingGeneralized Pustular Psoriasis | Erythrodermic PsoriasisJapan
-
Eli Lilly and CompanyCompletedGeneralized Pustular Psoriasis | Erythrodermic PsoriasisJapan
Clinical Trials on Individualized practical training
-
Kastamonu UniversityCompletedAutism Spectrum Disorder | ParentTurkey
-
Akdeniz UniversityCompletedIntensive Care Unit | Patient-Centered Care | Health Care Associated Infection | CompetenceTurkey
-
Federal University of Minas GeraisNot yet recruitingCerebral PalsyBrazil
-
Hospital of NavarraFundacion Miguel ServetNot yet recruitingSurgery--Complications
-
Taipei Medical UniversityNot yet recruiting
-
University of British ColumbiaCompletedChronic Obstructive Pulmonary DiseaseCanada
-
Universidad San SebastiánNot yet recruitingAthletic Performance | Aerobic Capacity | Rowing PerformanceChile
-
National Taiwan University HospitalCompletedPeripheral Arterial DiseaseTaiwan
-
Federal University of Juiz de ForaCompleted
-
Federal University of Minas GeraisConselho Nacional de Desenvolvimento Científico e TecnológicoUnknown